Larimar Therapeutics, Inc.
PHARMACEUTICAL COMPOSITION COMPRISING FRATAXIN FUSION PROTEIN AND METHODS OF USE THEREOF

Abstract:

Pharmaceutical compositions comprising a TAT-FXN fusion polypeptide are disclosed, as are methods of use of the pharmaceutical compositions to treat subjects diagnosed with Friedrich's Ataxia and/or hypertrophic cardiomyopathy.